Sandbox Turky2
Jump to navigation
Jump to search
| Rank | Journal | Website | Impact Factor |
|---|---|---|---|
| 1 | Circulation Research | http://circres.ahajournals.org/ | 11.019 |
| 2 | BLOOD | http://www.bloodjournal.org/ | 10.452 |
| 3 | LEUKEMIA | http://www.nature.com/leu/index.html | 10.431 |
| 4 | Stem Cells | http://goo.gl/o5cY16 | 6.523 |
| 5 | Arteriosclerosis, Thrombosis, and Vascular Biology | http://atvb.ahajournals.org/ | 6 |
| 6 | Haematologica | http://www.haematologica.org/ | 5.814 |
| 7 | The Journal of Thrombosis and Haemostasis | http://www.isth.org/?page=jth | 5.72 |
| 8 | Blood Reviews | http://www.bloodreviews.com/ | 5.565 |
| 9 | Journal Of Cerebral Blood Flow And Metabolism | http://www.nature.com/jcbfm/index.html | 5.407 |
| 10 | Thrombosis and Haemostasis | http://th.schattauer.de/ | 4.984 |
| 11 | British Journal of Haematology | http://goo.gl/s6y3Nl | 4.971 |
| 12 | Journal of Hematology & Oncology | http://www.jhoonline.org/ | 4.812 |
| 13 | Journal of Leukocyte Biology | http://www.jleukbio.org/ | 4.289 |
| 14 | Critical Reviews in Oncology/Hematology | http://www.croh-online.com/ | 4.027 |
| 15 | Current Opinion in Hematology | http://goo.gl/HhTuub | 3.97 |
| 16 | Seminars in Thrombosis and Hemostasis | http://goo.gl/z4bTOb | 3.876 |
| 17 | American Journal of Hematology | http://goo.gl/BpQeOs | 3.798 |
| 18 | Stem Cells and Development | http://goo.gl/rjmjOd | 3.727 |
| 19 | Bone Marrow Transplantation | http://www.nature.com/bmt/index.html | 3.57 |
| 20 | Biology of Blood and Marrow Transplantation | http://www.bbmt.org/ | 3.404 |
| Pathogen | Immunocompetent patients | Immunocompromised patients |
|---|---|---|
| Shigella species | TMP-SMZ, 160 and 800 mg, respectively (pediatric dose, 5 and 25 mg/kg, respectively) b.i.d. 3 3 d (if susceptiblea ) or fluoroquinolone (e.g., 300 mg ofloxacin, 400 mg norfloxacin, or 500 mg ciprofloxacin b.i.d. 3 3 d); nalidixic acid, 55 mg/kg/d (pediatric) or 1 g/d (adults) 3 5 d [220] or ceftriaxone azithromycin | 3 7–10 d |
| Non-typhi species of Salmonella | Not recommended routinely, but if severe or patient is !6 mo or 150 y old or has prostheses, valvular heart disease, severe atherosclerosis, malignancy, or uremia, TMP-SMZ (if susceptible) or fluoroquinolone as above, b.i.d. 3 5–7 d; ceftriaxone, 100 mg/kg/d in 1 or 2 divided doses | 14 d (or longer if relapsing) |
| Campylobacter species | Erythromycin, 500 mg b.i.d. 3 5 dc | Same (but may require prolonged treatment) |